Multiscale Profiling of Nanoscale Metal‐Organic Framework Biocompatibility and Immune Interactions
Advanced Healthcare Materials · 2025-11 · 14 (29)
DOI: 10.1002/adhm.202501809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.08.2025. Verfasst von Yunhui Zhuang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Adsorption & Advanced Materials Laboratory (AAML), Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Dr…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Biocompatible Materials. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPSRC, Department of Veterinary Medicine, University of Cambridge, Asthma and Lung UK.
Abstract (Originalsprache)
The clinical translation of metal‐organic frameworks (MOFs) – a promising class of porous materials for nanomedicine – is hindered by a poor understanding of their complex interactions with the immune system and in vivo immunotoxicity. To address this gap, a hierarchical “Safety‐by‐Design” pipeline is established and validated, integrating machine learning (ML) with ex vivo human blood studies and targeted in vivo models. This multi‐stage workflow enables the systematic profiling of MOF immunotoxicity, de‐risking their development. The power of this approach is demonstrated using four clinically relevant MOFs – NU‐901, PCN‐222, UiO‐66, and ZIF‐8 – revealing distinct, framework‐dependent immune fingerprints. The initial in silico screening correctly flagged NU‐901 and ZIF‐8 as potential hazards to human health. These predictions are subsequently validated ex vivo, where NU‐901 is confirmed to be selectively cytotoxic to CD14 + monocytes, and ZIF‐8 is identified as a specific pro‐inflammatory agent via IL‐6 induction. In contrast, candidates predicted to be safe – UiO‐66 and PCN‐222 – demonstrated high biocompatibility ex vivo and advanced to in vivo studies, where they caused only minimal and transient immune activation. This study provides a validated, resource‐efficient roadmap for preclinical immunotoxicity assessment, establishing a rational paradigm to accelerate the safe clinical translation of MOFs and other advanced nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adsorption & Advanced Materials Laboratory (AAML), Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK.
- Comprehensive Health Research Centre (CHRC), NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal.
- Cellular Imaging and Analysis Facility, Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK.
ORCID-Profile: David Fairen-Jimenez
Förderung
- EPSRC
- Department of Veterinary Medicine, University of Cambridge
- Asthma and Lung UK
- Engineering and Physical Sciences Research Council
- H2020 European Research Council
Zitieren
APA
Zhuang, Y., Mendes, B. B., Menon, D., Oliveira, J., Chen, X., Duman, F. D., Conniot, J., Mercado, S., Liu, X., Zhang, S. Y., Conde, J., Hewitt, R. E., & Fairen-Jimenez, D. (2025). Multiscale Profiling of Nanoscale Metal‐Organic Framework Biocompatibility and Immune Interactions. Advanced Healthcare Materials, 14(29). https://doi.org/10.1002/adhm.202501809
Vancouver
Zhuang Y, Mendes BB, Menon D, Oliveira J, Chen X, Duman FD, et al. Multiscale Profiling of Nanoscale Metal‐Organic Framework Biocompatibility and Immune Interactions. Advanced Healthcare Materials. 2025;14(29). doi:10.1002/adhm.202501809
BibTeX
@article{Zhuang2025,
author = {Zhuang, Yunhui and Mendes, Bárbara B and Menon, Dhruv and Oliveira, Jhenifer and Chen, Xu and Duman, Fatma Demir and Conniot, João and Mercado, Sergio and Liu, Xiewen and Zhang, Shi-Yuan and Conde, João and Hewitt, Rachel E and Fairen-Jimenez, David},
title = {Multiscale Profiling of Nanoscale Metal‐Organic Framework Biocompatibility and Immune Interactions},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {29},
doi = {10.1002/adhm.202501809}
}
EUVIMED